Related references
Note: Only part of the references are listed.Myeloid cells - targets of medication in multiple sclerosis
Manoj K. Mishra et al.
NATURE REVIEWS NEUROLOGY (2016)
Microvesicles: what is the role in multiple sclerosis?
Tiziana Carandini et al.
FRONTIERS IN NEUROLOGY (2015)
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Matias Saenz-Cuesta et al.
BIOMARKERS IN MEDICINE (2014)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acid sphingomyelinase activity triggers microparticle release from glial cells
Fabio Bianco et al.
EMBO JOURNAL (2009)
TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis
Kazuya Takahashi et al.
PLOS MEDICINE (2007)
Pathogenesis of multiple sclerosis: an update on immunology
B Hemmer et al.
CURRENT OPINION IN NEUROLOGY (2002)
Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli
C Buechler et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Share Paper
